Author
Listed:
- Moustapha Cissé
(Gladstone Institute of Neurological Disease
University of California)
- Brian Halabisky
(Gladstone Institute of Neurological Disease
University of California)
- Julie Harris
(Gladstone Institute of Neurological Disease
University of California)
- Nino Devidze
(Gladstone Institute of Neurological Disease)
- Dena B. Dubal
(Gladstone Institute of Neurological Disease
University of California)
- Binggui Sun
(Gladstone Institute of Neurological Disease
University of California)
- Anna Orr
(Gladstone Institute of Neurological Disease
University of California)
- Gregor Lotz
(Gladstone Institute of Neurological Disease
University of California)
- Daniel H. Kim
(Gladstone Institute of Neurological Disease)
- Patricia Hamto
(Gladstone Institute of Neurological Disease)
- Kaitlyn Ho
(Gladstone Institute of Neurological Disease)
- Gui-Qiu Yu
(Gladstone Institute of Neurological Disease)
- Lennart Mucke
(Gladstone Institute of Neurological Disease
University of California)
Abstract
Amyloid-β oligomers may cause cognitive deficits in Alzheimer’s disease by impairing neuronal NMDA-type glutamate receptors, whose function is regulated by the receptor tyrosine kinase EphB2. Here we show that amyloid-β oligomers bind to the fibronectin repeats domain of EphB2 and trigger EphB2 degradation in the proteasome. To determine the pathogenic importance of EphB2 depletions in Alzheimer’s disease and related models, we used lentiviral constructs to reduce or increase neuronal expression of EphB2 in memory centres of the mouse brain. In nontransgenic mice, knockdown of EphB2 mediated by short hairpin RNA reduced NMDA receptor currents and impaired long-term potentiation in the dentate gyrus, which are important for memory formation. Increasing EphB2 expression in the dentate gyrus of human amyloid precursor protein transgenic mice reversed deficits in NMDA receptor-dependent long-term potentiation and memory impairments. Thus, depletion of EphB2 is critical in amyloid-β-induced neuronal dysfunction. Increasing EphB2 levels or function could be beneficial in Alzheimer’s disease.
Suggested Citation
Moustapha Cissé & Brian Halabisky & Julie Harris & Nino Devidze & Dena B. Dubal & Binggui Sun & Anna Orr & Gregor Lotz & Daniel H. Kim & Patricia Hamto & Kaitlyn Ho & Gui-Qiu Yu & Lennart Mucke, 2011.
"Reversing EphB2 depletion rescues cognitive functions in Alzheimer model,"
Nature, Nature, vol. 469(7328), pages 47-52, January.
Handle:
RePEc:nat:nature:v:469:y:2011:i:7328:d:10.1038_nature09635
DOI: 10.1038/nature09635
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:469:y:2011:i:7328:d:10.1038_nature09635. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.